Skip to main content
. 2021 Jun 11;11(6):e044319. doi: 10.1136/bmjopen-2020-044319

Table 2.

In-hospital outcomes before and after propensity score matching

Before matching After matching
Statin (+) Statin (−) P value Standardised difference Statin (+) Statin (−) P value Standardised difference
n=1065 n=1523 n=936 n=936
All-cause mortality, n (%) 27 (2.5) 43 (2.8) 0.66 0.02 20 (2.1) 23 (2.5) 0.64 0.02
Acute kidney injury, n (%) 111 (10.4) 178 (11.7) 0.31 0.04 96 (10.3) 105 (11.2) 0.50 0.03
Stroke, n (%) 27 (2.5) 34 (2.2) 0.62 0.02 24 (2.6) 19 (2.0) 0.44 0.04
Vascular complication, n (%) 105 (9.9) 128 (8.4) 0.21 0.05 90 (9.6) 78 (8.3) 0.33 0.05
Postprocedural echocardiographic data
Effective orifice area, cm2 1.67±0.45 1.69±0.45 0.53 0.03 1.68±0.44 1.66±0.43 0.34 0.04
Indexed effective orifice area, cm2/m2 1.17±0.32 1.20±0.31 0.02 0.10 1.18±0.32 1.18±0.30 0.99 <0.01
Mean aortic gradient, mm Hg 11.0±4.4 10.6±4.7 0.08 0.07 11.0±4.4 11.0±4.9 0.92 <0.01
Peak velocity, m/s 2.3±0.4 2.2±0.5 0.10 0.07 2.3±0.5 2.3±0.5 0.98 <0.01
Moderate or severe aortic regurgitation, n (%) 18 (1.7) 31 (2.1) 0.51 0.03 17 (1.8) 20 (2.2) 0.61 0.02
Moderate or severe mitral regurgitation, n (%) 59 (5.6) 100 (6.6) 0.27 0.04 45 (4.8) 51 (5.5) 0.52 0.03